» Articles » PMID: 37803087

Replacement of Saturated Fatty Acids with Linoleic Acid in Western Diet Attenuates Atherosclerosis in a Mouse Model with Inducible Ablation of Hepatic LDL Receptor

Overview
Journal Sci Rep
Specialty Science
Date 2023 Oct 6
PMID 37803087
Authors
Affiliations
Soon will be listed here.
Abstract

Dietary saturate fatty acids (SFAs) have been consistently linked to atherosclerosis and obesity, both of which are characterized by chronic inflammation and impaired lipid metabolism. In comparison, the effects of linoleic acid (LA), the predominant polyunsaturated fatty acid in the Western diet, seem to diverge. Data from human studies suggest a positive association between high dietary intake of LA and the improvement of cardiovascular risk. However, excessive LA intake has been implicated in the development of obesity. Concerns have also been raised on the potential pro-inflammatory properties of LA metabolites. Herein, by utilizing a mouse model with liver-specific Ldlr knockdown, we directly determined the effects of replacing SFAs with LA in a Western diet on the development of obesity and atherosclerosis. Specifically, mice treated with a Ldlr ASO were placed on a Western diet containing either SFA-rich butter (WD-B) or LA-rich corn oil (WD-CO) for 12 weeks. Despite of showing no changes in body weight gain or adiposity, mice on WD-CO exhibited significantly less atherosclerotic lesions compared to those on WD-B diet. Reduced lesion formation in the WD-CO-fed mice corresponded with a reduction of plasma triglyceride and cholesterol content, especially in VLDL and LDL, and ApoB protein levels. Although it increased expression of proinflammatory cytokines TNF-α and IL-6 in the liver, WD-CO did not appear to affect hepatic injury or damage when compared to WD-B. Collectively, our results indicate that replacing SFAs with LA in a Western diet could reduce the development of atherosclerosis independently of obesity.

Citing Articles

Conjugated Linoleic Acid Production in Pine Nut Oil: A Fermentation Approach.

Wei G, Wu G, Sun J, Qi Y, Zhao Q, Xu F Foods. 2024; 13(16).

PMID: 39200400 PMC: 11353962. DOI: 10.3390/foods13162472.


Characterization of active peptides derived from three leeches and comparison of their anti-thrombotic mechanisms using the tail vein thrombosis model in mice and metabonomics.

Dong W, Li H, Li Y, Wang Y, Dai L, Wang S Front Pharmacol. 2024; 14:1324418.

PMID: 38333223 PMC: 10851270. DOI: 10.3389/fphar.2023.1324418.

References
1.
Lusis A . Atherosclerosis. Nature. 2000; 407(6801):233-41. PMC: 2826222. DOI: 10.1038/35025203. View

2.
Soehnlein O, Libby P . Targeting inflammation in atherosclerosis - from experimental insights to the clinic. Nat Rev Drug Discov. 2021; 20(8):589-610. PMC: 8112476. DOI: 10.1038/s41573-021-00198-1. View

3.
Rocha V, Libby P . Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol. 2009; 6(6):399-409. DOI: 10.1038/nrcardio.2009.55. View

4.
Wang B, Mintz G, Witzenbichler B, Souza C, Metzger D, Rinaldi M . Predictors and Long-Term Clinical Impact of Acute Stent Malapposition: An Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents (ADAPT-DES) Intravascular Ultrasound Substudy. J Am Heart Assoc. 2016; 5(12). PMC: 5210413. DOI: 10.1161/JAHA.116.004438. View

5.
Hammad S, Jones P . Dietary Fatty Acid Composition Modulates Obesity and Interacts with Obesity-Related Genes. Lipids. 2017; 52(10):803-822. DOI: 10.1007/s11745-017-4291-9. View